Neuren and Metabolic to Develop Nerve Repair Compounds

Neuren Pharmaceuticals and Metabolic Pharmaceuticals have agreed to collaborate to co-develop a class of nerve repair compounds for the treatment of degenerative conditions such as peripheral neuropathy, motor neuron disease and repairing the brain or nerves after injuries. Neuren Pharmaceuticals and Metabolic Pharmaceuticals will jointly develop Neuren's class of neuro-regenerative peptides (NRPs) with all intellectual property and commercial outcomes to be equally shared.

Yahoo News (http://uk.biz.yahoo.com/050307/241/fdve2.html)